Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the ...

The big difference between SPF oils and lotions is texture and sunscreen-filter options. SPF oils rely on chemical sunscreens ...

The National Football League has banned the use of smelling salts ahead of the 2025 season. The announcement was made via ...

It’s funny for about 30 seconds,” said a concertgoer outside Red Rocks Amphitheatre, who was preparing to inhale nitrous ...

In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical ...

Respiree announced that it received a second FDA 510(k) clearance for its RS001 cardio-respiratory wearable device.

The International Academy of Oral Medicine and Toxicology (IAOMT) and the Dental Amalgam Mercury Solutions (DAMS INC) have ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

SynOx Therapeutics has completed subject enrolment in its multi-centre Phase III TANGENT trial of emactuzumab for TGCT.

Connecticut is now participating in a new federal program aimed at expanding treatment access for patients with sickle cell ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

Some people claim raw milk has a better taste and can protect them from asthma and allergies. But public health professor ...